Publicatieoverzicht 2008 LUMC Maag-, darm- en leverziekten
Datum Dissertatie Artikelen niet in pubmed en ISI Artikelen en brieven in pubmed Artikelen en brieven in Thompson ISI
: : : : :
29-01-2009 1 3 1 43
Dissertatie 1.
Beek, W.P. van der (2008, april 03). Neuropeptide receptor expression in inflammatory bowel disease. Universiteit Leiden (143 pag.) (Leiden). Prom./coprom.: prof.dr. C.B.H.W. Lamers, & dr. I. Biemond.
Artikel - letter to the editor 1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Barros,R., Pereira, B., Duluc, I., Azevedo, M., Mendes, N., Camilo, V., Jacobs, R.J., Paulo, P., Santos-Silva, F., Seuningen, I. van, Brink, G.R. van den, David, L., Freund, J.N., Almeida, R. (2008). Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines. The Journal of Pathology 215(4) 411-420. Beek, W.P. ter, Muller, E.S.M., Berg, M. van den, Meijer, M.J.W., Biemond, I. & Lamers, C.B.H.W. (2008). Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine. Inflammatory Bowel Diseases. 14(5) 612-619. Bülow, S., Bülow, C., Vasen, H.F.A., Järvinen, H.J., Björk, J., Christensen, I.J. (2008). Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Diseases of the Colon & Rectum 51(9) 1318-1323. Burn,J., Bishop, D.T., Mecklin, J.P., Macrae, F., Moslein, G., Olschwang, S., Bisgaard, M.L., Ramesar, R., Eccles, D., Maher, E.R., Bertario, L., Jarvinen, H.J., Lindblom, A., Evans, D.G., Lubinski, J., Morrison, P.J., Ho, J.W.C., Vasen, H.F.A., Side, L., Thomas, H.J.W., Scott, R.J., Dunlop, M., Barker, G., Elliott, F., Jass, J.R., Fodde, R., Lynch, H.T., Mathers, J.C. (2008). Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. New England Journal of Medicine 2008; 359(24) 2567-2578. Buuren, H.R. van, Wils, A., Rauws, E.A.J., Hoek, B. van, Drenth, J.P.H., Kuipers, E.J., Pattynama, P.M.T. (2008). Nederlandse studie naar de beste behandelstrategie bij patiënten met een eerste of tweede oesofagus- of maagvaricesbloeding: de TIPS-TRUEtrial. Nederlands Tijdschrift voor Geneeskunde 152(11) 643-645. Derijks, L.J.J., Helden, R.B. van, Hommes, D.W., Stokkers, P.C. (2008) Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients. Gut 57(6) 872-872. Douma, K.F.L., Aaronson, N.K., Vasen, H.F.A., Bleiker, E.M.A. (2008). Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psycho-Oncology 17(8) 737-745. Eshuis, E.J., Polle, S.W., Slors, J.F., Hommes, D.W., Sprangers, M.A.G., Gouma, D.J., Bemelman, W.A. (2008). Long-term surgical recurrence, morbidity, quality of life, and body image of laparoscopic-assisted vs. open ileocolic resection for Crohn's disease: A comparative study. Diseases of the colon and rectum 15(6): 858-867. Friederich, P., Jong, A.E. de, Mathus-Vliegen, L.M., Dekker, E., Krieken, H.H., Dees, J., Nagengast, F.M., Vasen, H.F.A. (2008). Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis. Clinical gastroenterology and hepatology 6(11) 1237-1242. Gelinck, L.B.S., Bijl, A.E. van der, Beyer, W.E.P., Visser, L.G., Huizinga, T.W.J., Hogezand, R.A. van, Rimmelzwaan, G.F. & Kroon, F.P. (2008). The effect of anti-tumor
11.
12. 13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23. 24.
necrosis factor alpha treatment on the antibody response to influenza vaccination. Annals of the Rheumatic Diseases 67(5) 713-716. Gelinck, L.B.S., Bijl, A.E. van der, Visser, L.G., Huizinga, T.W.J., Hogezand, R.A. van, Rijkers, G.T., Kroon, F.P. (2008). Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine. Vaccine 26(26-27) 3528-3533. Gooskens, J., Coenraad, M.J., Prins, F.A., Smit, V.T.H.B.M., Groeneveld, J.H.M. (2008). Clinical Challenges and Images in GI. Gastroenterology 135(2) 363,716. D'Haens, G., Baert, F., Assche, G. van, Caenepeel, Ph., Vergauwe,Ph., Tuynman, H., Vos, M. de, Deventer, S.J.H. van, Stitt, L., Donner, A., Vermeire, S., Mierop, FJ. van de, Coche, J.Ch., Woude, J. van der, Ochsenkuhn, T., Bodegraven, A.A. van, Hootegem, P.P. van, Lambrecht, G.L., Mana, F., Rutgeerts, P., Feagan, B.G., Hommes, D.W. (2008). Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371(9613) 660667. Hardwick, J.C.H., Kodach, L.L., Offerhaus, G.J.A., Brink, G.R. van den. (2008). Bone morphogenetic protein signalling in colorectal cancer. Nature reviews Cancer 8(10) 806812. Hawinkels, L.J.A.C., Zuidwijk, K., Verspaget, H.W., Jonge-Muller, E.S.M. de, Duijn, W. van, Ferreira, V., Fontijn, R.D., David, G., Hommes, D.W., Lamers, C.B.H.W., Sier, C.F.M. (2008). VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. European journal of cancer 44(13) 1904-1913. Hes, F.J., Nielsen, M., Bik, E.C., Konvalinka, D, Wijnen, J.T., Bakker, E., Vasen, H.F.A., Breuning, M.H., & Tops, C.M.J. (2008). Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut 57(1) 71-76. Hommes, D.W., Erkelens, W., Ponsioen, C., Stokkers, P.C.F., Rauws, E., Spek, M. van der, Kate, F. ten, Deventer, S.J.H.van. (2008). A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis. Journal of Clinical Gastroenterology 42(5) 522-526. Hopman, E.G.D., Blomberg, M.E. von, Batstra, M.R., Morreau, H., Dekker, F.W., Koning, F., Lamers, C.B.H.W., Mearin, M.L. (2008). Gluten tolerance in adult patients with celiac disease 20 years after diagnosis? European journal of gastroenterology & hepatology 20(5) 423-429. Hove, W.R. ten, Rooij, B.F. de, van Hoek, B., Kuyvenhoven, J.P., Meijer, M.J.W., Berg, M. van den, Reijden, J.J. van der, Verduyn, W., Dubbeld, J., Hommes, D.W., Lamers, C.B.H.W., Verspaget, H.W. (2008). MMP-2 and MMP-9 serum levels change but their gene promoter polymorphisms are not associated with late phase I/R injury or rejection after orthotopic liver transplantation. The Open Transplantation Journal 2 66-72. Koch, A.D., Buzink, S.N., Heemskerk, J., Botden, S.M.B.I., Veenendaal, R.A., Jakimowicz, J.J. & Schoon, E.J. (2008). Expert and construct validity of the Simbionix GI Mentor II endoscopy simulator for colonoscopy. Surgical Endoscopy 22(1) 158-162. Kodach, L.L., Bleuming, S.A., Musler, A.R., Peppelenbosch, M.P., Hommes, D.W., Brink, G.R. van den, Noesel, C.J.M. van, Offerhaus, G.J.A. & Hardwick, J.C.H. (2008). The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Cancer 112(2) 300-306. Kodach, L.L., Wiercinska, E., Miranda, N.F.C.C. de, Bleuming, S.A., Musler, A.R., Peppelenbosch, M.P., Dekker, E., Brink, G.R. van den, Noesel, C.J.M. van, Morreau, H., Hommes, D.W., Dijke, P. ten, Offerhaus, G.J.A., Hardwick, J.C.H. (2008).The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology 134(5) 1332-1341. Koornstra, J.J., Kleibeuker, J.H., Vasen, H.F.A. (2008). Small-bowel cancer in Lynch syndrome: is it time for surveillance? The lancet oncology 9(9) 901-905. Korstanje, A., Eeden, S. van, Offerhaus, G.J.A., Waltman, F.L., Hartog, G. den., Roelandse, F.W.C., Souverijn, J.H.M., Biemond, I. & Lamers, C.B.H.W. (2008). Comparison between serology and histology in the diagnosis of advanced gastric body
25.
26.
27.
28.
29.
30.
31.
32. 33.
34.
35.
36.
37.
38.
atrophy: A study in a Dutch primary community. Journal of Clinical Gastroenterology 42(1) 18-22. Langers, A.M.J., Sier, C.F.M., Hawinkels, L.J.A.C., Kubben, F.J.G.M., Duijn, W. van, Reijden, J.J. van der, Lamers, C.B.H.W., Hommes, D.W., Verspaget, H.W. (2008). MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not. British Journal of Cancer 98(11) 1820-1823. Langers, A.M.J., Vos Tot Nederveen Cappel, W.H. de, Veenendaal, R.A., Bonsing, B.A., Hardwick, J.C.H., Vasen, H.F.A. (2008). Double balloon endoscopy for detection of smallbowel adenomas in familial adenomatous polyposis after pancreaticoduodenectomy according to Whipple. Endoscopy 40(9) 773-774. Langers, P., Press, R.R., Hartigh, J.D., Cremers, S.C.L.M., Baranski, A.G., Lamers, C.B.H.W., Hommes, D.W., Hoek, B. van. (2008). Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration. Therapeutic drug monitoring 30(4) 456-461. Löwenberg, M., Stahn, C., Hommes, D.W. & Buttgereit, F. (2008). Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 73(9-10) 1025-1029. Lutgens, M.W.M.D., Vleggaar. F.P., Schipper, M.E.I., Stokkers, P.C.F., Woude, J. van der, Hommes, D.W., de Jong, D.J., Dijkstra, G., Bodegraven, A.A. van, Oldenburg, B., Samsom, M. (2008). High frequency of early colorectal cancer in inflammatory bowel disease. Gut 57(9) 1246-1251. Middeldorp, A., Puijenbroek, M. van, Nielsen, M., Corver, W.E., Jordanova, E.S., Haar, N. ter, Tops, C.M.J., Vasen, H.F.A., Lips, E.H., Eijk, R. van, Hes, F.J., Oosting, J., Wijnen, J., Wezel, T. van, Morreau, H. (2008). High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas. Journal of Pathology 216(1) 25-31. Nieuwenhuis, M.H., Vos tot Nederveen Cappel, W.H. de, Botma, A., Nagengast, F.M., Kleibeuker, J.H., Mathus-Vliegen, E.M.H., Dekker, E., Dees, J., Wijnen, J.T. & Vasen, H.F.A. (2008). Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clinical gastroenterology and hepatology 6(2) 215-219 Noomen,C.G., Veenendaal, R.A. & Verspaget H.W. (2008. Gastroduodenal Crohn's disease and pancreatitis. Gastroenterology & Hepatology 4(7) 496-498. Puijenbroek, M. van, Nielsen, M., Tops, C.M.J., Halfwerk, H., Vasen, H.F.A., Weiss, M.M., Wezel, T. van, Hes, F.J., Morreau, H. (2008). Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clinical Cancer Research 14(1) 139-142. Puijenbroek, M. van, Middeldorp, A., Tops, C.M.J., Eijk, R. van, Klift, H.M. van der, Vasen, H.F.A., Wijnen, J.T., Hes, F.J., Oosting. J., Wezel. T. van, Morreau. H. (2008). Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas. Familial Cancer 7(4) 319-330. Reed, K.R., Athineos, D., Meniel, V.S., Wilkins, J.A., Ridgway, R.A., Burke, Z.D., Muncan, V., Clarke, A.R., Sansom, O.J. (2208). B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Proceedings of the National Academy of Sciences of the United States of America 105(48) 18919-18923. Sier, C.F.M., Hawinkels, L.J.A.C., Zijlmans, H.J.M.A.A., Zuidwijk, K., Jonge-Muller, E.S.M. de, Ferreira, V., Hanemaaijer, R., Mulder-Stapel, A.A., Kenter, G.G., Verspaget, H.W. & Gorter, A. (2008). Endothelium specific matrilysin (MMP-7) expression in human cancers. Matrix Biology 27(3) 267-271. Snoo, F.A. de, Bishop, D.T., Bergman, W., Leeuwen, I. van, Drift, C. van der, Nieuwpoort, F.A. van, Out-Luiting, C.J., Vasen, H.F.A., Huurne, J.A.C. ter, Frants, R.R., Willemze, R., Breuning, M.H. & Gruis, N.A.. (2008). Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res 14(21) 7151-7157. Snoo, F.A. de, Riedijk, S.R., Mil, A.M. van, Bergman, W., Huurne, J.A.C. ter, Timman, R., Bertina, W., Gruis, N.A., Vasen, H.F.A., Haeringen, A. van, Breuning, M.H. & Tibben, A.
39.
40. 41.
42.
43.
44.
45.
46.
47.
(2008) Genetic testing in familial melanoma: uptake and implications. Psycho-Oncology 17(8) 790-796. Stange, E.F., Travis, S.P.L., Vermeire, S., Reinisch, W., Geboes, K., Barakauskiene, A., Feakins, R., Fléjou, J.F., Herfarth, H., Hommes, D.W., Kupcinskas, L., Lakatos, P.L., Mantzaris, G.J., Schreiber, S., Villanacci, V. & Warren, B.F. (2008). European evidencebased Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn's and colitis 2008; 2: 1-23. Vasen, H.F.A. & Kate, G.L. ten (2008). Small bowel cancer: Should relatives be screened for Lynch syndrome? Authors' response. Gut 57(1) 140-140. Vasen, H.F.A., Möslein, G., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Blanco, I., Bülow, S., Burn, J., Capella, G., Colas, C., Engel, C., Frayling, I., Friedl, W., Hes, F.J., Hodgson, S., Järvinen, H.J., Mecklin, J.P., Møller, P., Myrhøj, T., Nagengast, F.M., Parc, Y., Phillips, R., Clark, S., Ponz de Leon, M., Renkonen-Sinisalo, L., Sampson, J, Stormorken, A., Tejpar, S., Thomas, H.J.W. & Wijnen, J.T. (2008). Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57(5) 704-713. Vasen, H.F.A. (2008). Can the identification of high risk groups increase the effectiveness of colon cancer screening programmes? Zeitschrift fur Gastroenterologie 46(Suppl. 1) 4142. Veek, P.P. van der, Rood, Y.R. van, Masclee, A.A.M. (2008). Symptom severity but not psychopathology predicts visceral hypersensitivity in Irritable Bowel Syndrome. Clinical gastroenterology and hepatology 6(3) 321-328 Vos Tot Nederveen Cappel, W.H.de, Dubbeld, J., Willems, S.M., Ringers, J., Hoek, B. van. (2008). Liver transplantation in a patient with encapsulating peritoneal sclerosis. The Netherlands Journal of Medicine 66(7) 280-282. Wasielewski, M., Vasen, H.F.A., Wijnen, J.T., Hooning, M., Dooijes, D., Tops, C.M.J., Klijn, J.G.M., Meijers-Heijboer, H., Schutte, M. (2008). CHEK2 1100delC is a susceptibility allele for HNPCC-related colorectal cancer. Clinical cancer research 14(15) 4989-4994. Watson, P., Vasen, H.F.A., Mecklin, J.P., Bernstein, I., Aarnio, M., Järvinen, H.J., Myrhøj, T., Sunde, L., Wijnen, J.T., Lynch, H.T. (2008). The risk of extra-colonic, extraendometrial cancer in the Lynch syndrome. International Journal of Cancer 123(2) 444449. Zelinkova, Z., Beelen A.J. van, Kort, F.de, Moerland, P.D., Ver Loren van Themaat, P.E., Velde, A.A. te, Deventer, S.J.H. van, Jong, E.C. de, & Hommes, D.W. (2008) Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells. Inflammatory bowel diseases 14(2) 186-194.
Publicaties waarin de afdeling ter sprake komt. 1. Heemskerk, R. (2008). Embryonale darmen. Cicero 2, 17. 2. Veld, D. de. (2008). Meteen de kop indrukken. Radicaal behandelschema is effectiever in bestrijding chronische darmontsteking. Cicero 3, 11. 3. Heemskerk, R. (2008). Kans op jaar in VS. Cicero 4, 7. 4. Baarsel, M. van. (2008). Parelpoetsers presenteren zich. Cicero 4, 18. 5. Veld, D. de. (2008). Galkristallen. Cicero 4, 25.. 6. Behandeling ziekte van Crohn kan veel beter. Persbericht LUMC Actueel 25 februari 2008. 7. Behandeling ziekte van Crohn kan veel beter. Nieuwsbericht UL 26 februari 2008. 8. De eerste klap. Meteen zware pillen helpt bij Crohn en reuma. NRC Handelsblad 12 april 2008. 9. Langer leven na levertransplantatie en met meer kwaliteit kan het resultaat zijn. Vitalia Nieuwsbrief Maag Lever Darm Stichting 2008 April blz 4-5 10. Heemskerk, R. (2008) Darmkankergevoeligheid ontmaskerd. Cicero 6, 17. 11. Heemskerk, R. (2008) Stamcel op drempel van behandelkamer. Cicero 9, 10. 12. Heemskerk, R. (2008) Portet van een veelzijdige pil. Cicero 10, 8
13. Aeijelts Averink G. (2008) De Nederlandse Vereniging voor Gastro-enterologie heeft de prijs voor het beste proefschrift op het gebied van maag-, darm- en leverziekten in 2007 toegekend aan Dr. A. van der Meulen- de Jong, arts-assistent in opleiding (Maag-,darmen leverziekten). Cicero 12 7 14. Hijlkema, S. (2008). Dikkedarmkanker kent vele gezichten. Cicero 12,16 15. Linsen, S. (2008). Meer of minder risico voor Lynch-syndroom patiënten. Cicero 13, 17. 16. Veld, D. de. (2008). Het huwelijk van zorg en onderzoek. Door CuraRata hebben patiënten direct profijt van wetenschap. Cicero 15, 23. 17. Linden, S. (2008). Bescherming houdt op waar Lynch Syndroom begint. Cicero 15, 27. 18. (2008). Vaker transplantatie bij levercelkanker mogelijk. LUMC Nieuwsoverzicht.
Publicaties van 2008 en 2007 die 10 of meer keer zijn geciteerd: 1. Vasen HFA, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Mecklin JP, Moller P, Nagengast F, Parc Y, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Wijnen J. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). Journal of Medical Genetics 2007; 44: 353-362.Times Cited: 40 2. D'Haens G, Baert F, van Assche G, Caenepeel P, Vergauwe P, Tuynman H, De Vos M, van Deventer S, Stitt L, Donner A, Vermeire S, Van De Mierop FJ, Coche JCR, van der Woude J, Ochsenkuhn T, van Bodegraven AA, van Hootegem PP, Lambrecht GL, Mana F, Rutgeerts P, Feagan BG, Hommes D. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008; 371: 660-667.Times Cited: 30 3. Van den Brink GR, Offerhaus GJ. The morphogenetic code and colon cancer development. Cancer Cell 2007; 11: 109-117.Times Cited: 14 4. Nieuwenhuis MH, Vasen HFA. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature. Critical Reviews in Oncology Hematology 2007; 61: 153-161.Times Cited: 12 5. Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Molecular and Cellular Endocrinology 2007; 275: 71-78.Times Cited: 11 6. Lowenberg M, Verhaar AP, van den Brink GR, Hommes DW. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends in Molecular Medicine 2007; 13: 158-163.Times Cited: 10
